This work is licensed under a Creative Commons Attribution 4.0 International License.
Sequence 34 from Patent US 20060122119
General Information
DRACP ID DRACP01267
Peptide Name Sequence 34 from Patent US 20060122119
Sequence ILDTAGQEEY
Sequence Length 10
UniProt ID Q54BW4 Q75J93 P01120 P01119 P01114 P22126 P22279 P51539 P34726 P01111 Q5RD87 Q91806 Q95ME4 B4LY29 P23175 P01112 P01113 B4NJ72 P12825 Q04970 P08556 P34729 P15064 B4JFU8 B3M185
PubChem CID Not available
Origin Homo sapiens
Type Native peptide
Classification
Active ACP
Activity Information
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Antitumor
Structure Information
Helicity Not available
Linear/Cyclic Not available
Disulfide/Other Bond Not available
N-terminal Modification Not available
C-terminal Modification Not available
Other Modification None
Chiral L
Physicochemical Information
Formula C49H75N11O20
Absent amino acids CFHKMNPRSVW
Common amino acids E
Mass 129892
Pl 3.42
Basic residues 0
Acidic residues 3
Hydrophobic residues 3
Net charge -3
Boman Index -1800
Hydrophobicity -63
Aliphatic Index 88
Half Life
Mammalian: 1.1 hour
Yeast: 3 min
E.coli: 2 min
Extinction Coefficient cystines 1490
Absorbance 280nm 165.56
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID Not available
Title Not available
Doi Not available
Year Not available
Patent
Patent ID US 2006/0122119 A1
Patent Title Peptides for use in antitumor immunotherapy.
Other Iinformation Granted Patent Family: 10s / 10ex; Family Jurisdictions: CA, AU, FR, WO, US, EP, JP; Legal Status: Discontinued; Application No: 50633405; Filed:May 25, 2005; Published: Jun 8, 2006; Earliest Priority: Mar 4, 2002
Other Published ID CA2477762A1 EP1481009A2 WO2003074565A2 WO2003074565A3
This work is licensed under a Creative Commons Attribution 4.0 International License.